- Home
- KYMR vs KEN Comparison
KYMR vs KEN Comparison
Compare KYMR & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- KEN
- Stock Information
- Founded
- KYMR 2015
- KEN 2014
- Country
- KYMR United States
- KEN Singapore
- Employees
- KYMR N/A
- KEN N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- KEN Electric Utilities: Central
- Sector
- KYMR Health Care
- KEN Utilities
- Exchange
- KYMR Nasdaq
- KEN Nasdaq
- Market Cap
- KYMR 1.8B
- KEN 1.8B
- IPO Year
- KYMR 2020
- KEN N/A
- Fundamental
- Price
- KYMR $45.87
- KEN $37.52
- Analyst Decision
- KYMR Strong Buy
- KEN
- Analyst Count
- KYMR 16
- KEN 0
- Target Price
- KYMR $59.38
- KEN N/A
- AVG Volume (30 Days)
- KYMR 1.1M
- KEN 17.9K
- Earning Date
- KYMR 08-06-2025
- KEN 05-28-2025
- Dividend Yield
- KYMR N/A
- KEN 12.82%
- EPS Growth
- KYMR N/A
- KEN N/A
- EPS
- KYMR N/A
- KEN 11.35
- Revenue
- KYMR $58,885,000.00
- KEN $760,304,000.00
- Revenue This Year
- KYMR $43.38
- KEN N/A
- Revenue Next Year
- KYMR $10.97
- KEN N/A
- P/E Ratio
- KYMR N/A
- KEN $3.26
- Revenue Growth
- KYMR N/A
- KEN 5.78
- 52 Week Low
- KYMR $19.45
- KEN $23.31
- 52 Week High
- KYMR $53.27
- KEN $37.77
- Technical
- Relative Strength Index (RSI)
- KYMR 67.58
- KEN 67.32
- Support Level
- KYMR $45.80
- KEN $34.52
- Resistance Level
- KYMR $47.51
- KEN $36.60
- Average True Range (ATR)
- KYMR 2.86
- KEN 0.62
- MACD
- KYMR -0.03
- KEN -0.02
- Stochastic Oscillator
- KYMR 67.19
- KEN 92.31
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.